首页 | 本学科首页   官方微博 | 高级检索  
检索        

C型凝集素受体在肿瘤免疫作用中的研究进展
引用本文:杨芸宁,徐媛媛,龙珊,李晓松.C型凝集素受体在肿瘤免疫作用中的研究进展[J].中国免疫学杂志,2019(9):1139-1142.
作者姓名:杨芸宁  徐媛媛  龙珊  李晓松
作者单位:中国人民解放军总医院第四医学中心
基金项目:国家自然科学基金(81572953)资助
摘    要:C型凝集素受体(CLRs)是一种高表达于树突状细胞(DCs)的模式识别受体(PRRs),它参与了由DCs介导的针对肿瘤的非特异性免疫和特异性免疫。激活表达于DCs上的CLRs可显著提升机体免疫系统对肿瘤细胞的杀伤作用。本文将以CLRs中的Dectin-1和Dectin-2受体为例,对其在肿瘤免疫中发挥的作用及参与此过程的相关信号通路进行综述,并据此初步探讨CLRs未来在肿瘤免疫治疗中可能的应用。

关 键 词:C型凝集素受体  癌症  肿瘤转移  DECTIN-1  Dectin-2  肿瘤免疫

Research progress on role of C-type lectin receptors in tumor immunotherapy
YANG Yun-Ning,XU Yuan-Yuan,LONG Shan,LI Xiao-Song.Research progress on role of C-type lectin receptors in tumor immunotherapy[J].Chinese Journal of Immunology,2019(9):1139-1142.
Authors:YANG Yun-Ning  XU Yuan-Yuan  LONG Shan  LI Xiao-Song
Institution:(The Fourth Medical Center of PLA General Hospital,Beijing 100048,China)
Abstract:As one of pattern recognition receptors,C-type lectin receptors(CLTs)were found to be highly expressed by dendritic cells(DCs) and play an important role in the non-specific immunity and specific immunity mediated by DCs towards cancer.Stimulating CLTs expressed on DCs will significantly improve the immunity toward tumor cells.In this review we discuss the role CLTs playing in immunotherapy for tumors and relative signaling pathways,then describe how CLTs can be used in future immunotherapy.
Keywords:C-type lectin receptors  Cancer  Tumor metastasis  Dectin-1  Dectin-2  Tumor immunotherapy
本文献已被 CNKI 维普 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号